QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nasdaq-notified-talis-biomedical-that-nasdaq-believes-co-is-public-shell--continued-listing-of-its-common-stock-is-no-longer-warranted

- SEC Filing

 why-talis-biomedical-tlis-stock-is-getting-obliterated-today

Talis Biomedical shares are trading lower by 49% to $4.58 during Wednesday's session. The company announced board restructu...

 talis-biomedicals-board-of-directors-initiated-a-sequence-of-actions-aimed-at-restructuring-the-boards-composition

-SEC Filing

 talis-biomedical-q4-eps-739-up-from-1515-yoy-sales-19500k-down-from-25700k-yoy

Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(7.39) per share. This is a 51.22 percent increase over losses of ...

 why-beyond-air-shares-are-trading-lower-by-around-37-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.

 why-talis-biomedical-tlis-stock-is-exploding-higher

Talis Biomedical Corp (NASDAQ: TLIS) shares are trading higher by 30% to $7.03 Tuesday morning after the company announced it i...

 azenta-reports-upbeat-earnings-joins-talis-biomedical-sally-beauty-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose...

 stocks-that-hit-52-week-lows-on-friday

  Friday's session saw 169 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 164 companies achieved new lows for the year.

 btig-maintains-sell-on-talis-biomedical-raises-price-target-to-5

BTIG analyst Mark Massaro maintains Talis Biomedical (NASDAQ:TLIS) with a Sell and raises the price target from $0.35 to $5.

 talis-biomedical-q2-eps-827-misses-073-estimate-sales-58100k-up-from-57200k-yoy

Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(8.27) per share which missed the analyst consensus estimate of $(...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION